Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 48220301000001112 | Neoclarityn (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 48220401000001116 | Neoclarityn | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Neoclarityn | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Neoclarityn 2.5mg/5ml syrup (Schering-Plough Ltd) | Is a | True | Neoclarityn | Inferred relationship | Existential restriction modifier | |
| Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) | Is a | True | Neoclarityn | Inferred relationship | Existential restriction modifier | |
| Neoclarityn 5mg tablets (Doncaster Pharmaceuticals Ltd) | Is a | True | Neoclarityn | Inferred relationship | Existential restriction modifier | |
| Neoclarityn 2.5mg/5ml syrup (Sigma Pharmaceuticals Plc) | Is a | True | Neoclarityn | Inferred relationship | Existential restriction modifier | |
| Neoclarityn 2.5mg/5ml oral solution (Organon Pharma (UK) Ltd) | Is a | True | Neoclarityn | Inferred relationship | Existential restriction modifier | |
| Neoclarityn 5mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Neoclarityn | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR